Latest News about NTLA
Recent news which mentions NTLA
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
December 31, 2023
From Motley Fool
5 Beaten-Down Stocks That Could Soar in 2024
December 16, 2023
From Motley Fool
3 Gene-Editing Stocks With the Potential to Mint Millionaires
December 13, 2023
From InvestorPlace
Could Intellia Therapeutics Become the Next CRISPR Therapeutics?
December 12, 2023
From Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
From Motley Fool
2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull Market
November 28, 2023
From Motley Fool
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 20, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
From Benzinga
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock
November 13, 2023
From Benzinga
3 Biotech Stocks That Are Betting on the Future of Gene Editing
November 09, 2023
From InvestorPlace
From Motley Fool
Tickers
NTLA
From Motley Fool
3 Stocks Cathie Wood Is Buying That Should Be on Your List Too
October 23, 2023
From Motley Fool
Cathie Wood Is Buying These Top Growth Stocks -- and Both Could Make You Richer Over Time
October 21, 2023
From Motley Fool
Cathie Wood's Ark Offloads $6.3M In Tesla Shares Amid EV Maker's Q3 Earnings Disappointment
October 18, 2023
From Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
From InvestorPlace
2 Healthcare Stocks Near 52-Week Highs Still Worth Buying
October 16, 2023
From Motley Fool
From Motley Fool
2 Brilliant Growth Stocks to Buy and Hold Forever
October 12, 2023
From Motley Fool
Cathie Wood's Ark Invest Sells $9.8M Worth Of Tesla Shares — Second Day Of Selling EV Giant In A Row
October 11, 2023
From Benzinga
Cathie Wood's Ark Invest Keeps On Cutting Tesla Holdings, Sells More Than $8M Worth Of EV Maker's Shares
October 10, 2023
From Benzinga
Down 45%, Is Intellia a Buy?
October 10, 2023
From Motley Fool
This Cathie Wood Stock Is Poised to Double, Says Wall Street
October 10, 2023
Tickers
NTLA
From Motley Fool
Tickers
NTLA
From Motley Fool
Better Gene Editing Stock: Intellia Therapeutics vs. Rocket Pharmaceuticals
September 23, 2023
From Motley Fool
1 Huge Risk That Gene-Editing Stock Investors Desperately Need to Know
September 19, 2023
From Motley Fool
2 Top Trends to Invest $500 In Right Now
September 18, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.